Protected Nucleosides
(2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid
Quick view. We supply (2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid as a base- or sugar-protected nucleoside intermediate for nucleoside, nucleotide and oligonucleotide building-block synthesis. CAS 174653-39-5. Catalog target purity: Specification on request.
Structure and identity
The structure drawing for this item is being finalized. Use the CAS number and machine-readable identifiers below to confirm the requested protecting groups, stereochemistry, salt or counterion and hydration state before ordering.
CAS, molecular formula, SMILES or InChI data are shown below when available.
We withhold a drawing when a related compound, alternate salt or incompletely specified stereoisomer could be mistaken for the requested material.
Agreed identity and purity criteria are documented in the quotation, specification and lot-specific data package.
Product profile
(2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid is classified as nucleoside or protected nucleoside intermediate (Formula C16H18N2O11; molecular weight 414.32).
(2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For (2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid, functional handles may require orthogonal protection, pH control and rapid purification to avoid hydrolysis, oxidation or cross-reaction.
Names and search terms
Useful catalog search terms
- CAS 174653-39-5
- Nucleoside or protected nucleoside intermediate
- Protected Nucleosides
Physicochemical data
| Density | 1.54±0.1 g/cm3(Predicted) |
|---|---|
| pKa | 4.99±0.20(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Product-specific evaluation notes
Potential advantages
- Reactive handles make the product adaptable across dye-labeling, surface-coupling and ligand-conjugation workflows.
Method limitations
- Functional handles may require orthogonal protection, pH control and rapid purification to avoid hydrolysis, oxidation or cross-reaction.
These points describe (2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
2'-O-TBDMS-rG(iBu)
Protected Nucleosides · CAS: 182007-86-9
BX-PN-00435'-O-DMTr-2'-O-TBDMS-rC(Ac)
Protected Nucleosides · CAS: 121058-85-3
BX-PN-00575'-O-TBDMS-3'-O-TBDMS-5-(hydroxymethyl)-dC
Protected Nucleosides · CAS: 1257247-39-4
BX-PN-00585'-O-TBDMS-3'-O-TBDMS-5-I-dC
Protected Nucleosides · CAS: 478843-96-8
BX-PN-00607'-O-TBDMS-4'-N-Trt-PMO-G(iBu)
Protected Nucleosides · CAS: N/A
BX-PN-00673'-O-TBDMS-2'-F-dG(iBu)
Protected Nucleosides · CAS: 2382967-92-0
Frequently asked questions
Can the package size for (2',3',5'-Tri-O-acetyl)uridine 5-carboxylic acid be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-PN-0175 and CAS 174653-39-5, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Protected Nucleosides product family and its named chemistry.